Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-01-22 | State Street Global Advisors, Inc.Società | -13,74M | 64,56k | Other Disposition | 13,77 - 16,87 | 49,32M | -21,79% |
| 2024-04-23 | State Street Global Advisors, Inc.Società | -131,23M | 351,73M | Other Disposition | 10,38 - 19,50 | 41,55M | -75,95% |
| 2025-11-18 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | 233,76k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-18 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | -122,57k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-11-18 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | 34,17k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-20 | Dr. James Pacey NewcombeMD, CEO & Executive Director | 50,48k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-20 | Dr. James Pacey NewcombeMD, CEO & Executive Director | 345,34k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-18 | Dr. Colin Stephen GoldschmidtInsider | -321,64k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-10-16 | Ms. Nicola M. Wakefield EvansIndependent Non-Executive Director | 2,50k | 35,39k | Acquisto | 14,16 | 6,50k | 62,50% |
| 2025-10-03 | Dr. Katharine GilesIndependent Non-Executive Director | 1.000,00 | 14,35k | Acquisto | 14,35 | 4,60k | 27,78% |
| 2025-10-02 | Prof. Mark R. ComptonIndependent Non-Executive Chairman | 1,50k | 21,30k | Acquisto | 14,20 | 17,02k | 9,67% |
| 2025-10-01 | Prof. Christine Constance BennettIndependent Non-Executive Director | 1,10k | 15,62k | Acquisto | 14,20 | 8,20k | 15,49% |
| 2025-09-24 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | -111,59k | 0,00 | Other Derivative Disposition | 21,62 | - | - |
| 2025-09-24 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | -19,62k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-09-24 | Dr. Colin Stephen GoldschmidtInsider | -265,92k | 0,00 | Other Derivative Disposition | 21,62 | - | - |
| 2025-09-24 | Dr. Colin Stephen GoldschmidtInsider | -46,75k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-09-26 | Prof. Suzanne CroweNon-Executive Independent Director | 2,37k | 32,68k | Acquisto | 13,82 | 9,91k | 31,33% |
| 2025-09-26 | Ms. Kathryn Dianne SpargoNon-Executive Independent Director | 3,50k | 48,70k | Acquisto | 13,91 | 31,00k | 12,73% |
| 2025-09-02 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 630,56k | 0,60% |
| 2025-09-02 | Dr. Colin Stephen GoldschmidtInsider | 9,85k | 0,00 | Derivative Exercise and Retained Stock | - | 1,00M | 0,99% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
